Your browser doesn't support javascript.
loading
Response to First Cycle Is the Major Predictor of Long-Term Response to Lenalidomide and Dexamethasone Therapy in Relapsed and Refractory Multiple Myeloma: Can We Spare Patients the Toxicity and Costs of Additional Agents?
Gassiot, Susanna; González, Yolanda; Morgades, Mireia; Motlló, Cristina; Clapés, Victòria; Maluquer, Clara; Ibarra, Gladys; Abril, Laura; Ribera, Josep-Maria; Oriol, Albert.
Afiliação
  • Gassiot S; Institut Català d'Oncologia, Hospital Germans Trias i Pujol, Josep Carreras Leukaemia Research Institute, Departament de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain. Electronic address: sgassiot@iconcologia.net.
  • González Y; Institut Català d'Oncologia, Hospital Josep Trueta, Girona, Spain.
  • Morgades M; Institut Català d'Oncologia, Hospital Germans Trias i Pujol, Josep Carreras Leukaemia Research Institute, Badalona, Spain.
  • Motlló C; Institut Català d'Oncologia, Hospital Germans Trias i Pujol, Josep Carreras Leukaemia Research Institute, Badalona, Spain.
  • Clapés V; Institut Català d'Oncologia, Hospital Duran i Reynals, L'Hospitalet de Llobregat, Llobregat, Spain.
  • Maluquer C; Institut Català d'Oncologia, Hospital Germans Trias i Pujol, Josep Carreras Leukaemia Research Institute, Badalona, Spain.
  • Ibarra G; Institut Català d'Oncologia, Hospital Germans Trias i Pujol, Josep Carreras Leukaemia Research Institute, Badalona, Spain.
  • Abril L; Institut Català d'Oncologia, Hospital Germans Trias i Pujol, Josep Carreras Leukaemia Research Institute, Badalona, Spain.
  • Ribera JM; Institut Català d'Oncologia, Hospital Germans Trias i Pujol, Josep Carreras Leukaemia Research Institute, Departament de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Oriol A; Institut Català d'Oncologia, Hospital Germans Trias i Pujol, Josep Carreras Leukaemia Research Institute, Departament de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain.
Clin Lymphoma Myeloma Leuk ; 19(9): 585-592.e1, 2019 09.
Article em En | MEDLINE | ID: mdl-31255588
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Mieloma Múltiplo Tipo de estudo: Clinical_trials / Diagnostic_studies / Health_economic_evaluation / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Mieloma Múltiplo Tipo de estudo: Clinical_trials / Diagnostic_studies / Health_economic_evaluation / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article